We bring value, innovation and growth to your business
Drug Discovery Alliances is in the business of providing solutions to pharmaceutical companies by providing a wide range of contract and consulting services for driving drug candidate programs from research through development to commercialization both economically and efficiently. Drug Discovery Alliances has been in business for close to a decade and has amassed a very impressive pharmaceutical client base of over a hundred pharmaceutical companies worldwide.
In addition to these services, Drug Discovery Alliances also offers CMC consulting to help manage many aspects of an R&D program.
Services provided through Drug Discovery Alliances range from pre-clinical to commercial, including: in-vitro ADME toxicology, process research, medicinal chemistry, cGMP manufacturing, formulation and final dose manufacturing, sourcing of raw materials and advanced intermediates throughout India, Japan and China. Also, consultants are available to assist in managing the CMC efforts of companies, including the writing of IND’s and NDA’s.
Drug Discovery Alliances will be attending the Informex 2010 in February.
Drug Discovery Alliances recently added PII and Pharmaterials to the portfolio. These companies offer a wider range formulation/solid form and final dose capabilities spanning from preclinical to commercial.
Regis just achieves a successful PAI inspection for Biogen Idec compound (visit their website for more details www.registech.com)